Search results
Analyst Report: Vertex Pharmaceuticals Incorporated
Morningstar Research via Yahoo Finance· 1 day agoVertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco ...
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
GuruFocus.com via Yahoo Finance· 2 days agoStrategic Acquisition: Announced the acquisition of Alpine Immune Sciences, enhancing the pipeline...
Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy...
FierceBiotech· 2 days agoVertex Pharmaceuticals is ahead of schedule, filing a new drug application for its next-gen cystic fibrosis (CF) treatment dubbed vanza triple. Vertex completed ...
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Reuters via AOL· 2 days ago(Reuters) -Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday,...
Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
GuruFocus.com via Yahoo Finance· 2 days agoRelease Date: May 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Vertex Pharmaceuticals Inc ...
Fisher Asset Management LLC Purchases 108 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 2 days agoFisher Asset Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.4% during the 4th quarter, according to the company ...
Analyst Report: CRISPR Therapeutics AG
Morningstar Research via Yahoo Finance· 3 hours agoThe company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex</ ...
Vertex Inc (VERX) Q1 2024 Earnings: Surpasses Revenue Expectatio
Guru Focus· 11 hours agoRevenue: Reported at $156.78 million, surpassing the estimate of $154.91 million.Net Income: Achieved $2.68 million, below expectations compared to the estimat
Vertex Energy Inc (VTNR) Stock: Understanding the Volatility – News Heater
NewsHeater· 2 days agoThe stock of Vertex Energy Inc (VTNR) has gone up by 11.15% for the week, with a 13.78% rise in the past month and a 2.48% rise in the past quarter. The volatility ratio for ...
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
WSAU Wausau· 2 days ago(Reuters) - Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday,...
